396 results on '"Speletas, Matthaios"'
Search Results
2. CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling Responses
3. Heterozygous SERPINA1 Defects and Their Impact on Clinical Manifestations of Patients with Predominantly Antibody Deficiencies
4. A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and CTLA4-Mediated Immune Dysregulation Syndrome in Greece
5. Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosage
6. Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Parkinson’s Disease Patients and Healthy Controls
7. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
8. MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19
9. COVID-19 Outbreak on a Passenger Ship and Assessment of Response Measures, Greece, 2020
10. A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency
11. International Consensus on the Use of Genetics in the Management of Hereditary Angioedema
12. TNFRSF13C/BAFFR P21R and H159Y polymorphisms in multiple sclerosis
13. Dynamics of Anti-SARS-CoV-2 IgA and IgG Responses and Their Protective Effect against Fatal Disease after Booster COVID-19 Vaccination
14. Does tourism affect the long term course of COVID-19 pandemic in a country of destination? Evidence from a popular Greek island in 2020 where control measures were implemented.
15. Dynamics of Anti-SARS-CoV-2 IgA and IgG Responses and Their Protective Effect against Fatal Disease after Booster COVID-19 Vaccination.
16. Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis
17. P-372 Transcriptomic expression of BMP-2, BMP-6 and Smad6 genes in newly diagnosed and relapsed multiple myeloma patients
18. Innate Immune Gene Polymorphisms and COVID-19 Prognosis
19. Molecular Analysis of Hot-Spot Regions of ACE2 and TMPRSS2 in SARS-CoV-2 “Invulnerable” Individuals
20. Awareness of thrombotic disease during lockdown: an unusual consequence of the COVID-19 pandemic
21. Does tourism affect the long term course of COVID-19 pandemic in a country of destination? Evidence from a popular Greek island in 2020 where control measures were implemented
22. Measles Immunity Status of Greek Population After the Outbreak in 2017-2018: Results From a Seroprevalence National Survey
23. Wastewater Levels of Respiratory Syncytial Virus Associated with Influenza-like Illness Rates in Children—A Case Study in Larissa, Greece (October 2022–January 2023)
24. Measles Immunity Status of Greek Population after the Outbreak in 2017–2018: Results from a Seroprevalence National Survey.
25. Genetic polymorphisms of innate and adaptive immunity as predictors of outcome in critically ill patients
26. Peripheral Inflammatory Markers TNF-α and CCL2 Revisited: Association with Parkinson’s Disease Severity
27. The rs1883832 Polymorphism (CD40-1C>T) Affects the Intensity of IgA Responses after BNT162b2 Vaccination
28. CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling Responses
29. TNFRSF13B/TACI Mutations in Patients with Chronic Rhinosinusitis with Nasal Polyps
30. Machine-Learning-Assisted Analysis of TCR Profiling Data Unveils Cross-Reactivity between SARS-CoV-2 and a Wide Spectrum of Pathogens and Other Diseases
31. Genetics of Hereditary Angioedema Revisited
32. Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines
33. Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Different States of Bipolar Disorder
34. Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)
35. Checkpoint modulation in chronic hepatitis B: From hypothesis to approval
36. TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment
37. Prevalence and Predictors of COVID-19 Vaccination Acceptance among Greek Health Care Workers and Administrative Officers of Primary Health Care Centers: A Nationwide Study Indicating Aspects for a Role Model
38. Machine learning assisted analysis on TCR profiling data from COVID-19-convalescent and healthy individuals unveils cross-reactivity between SARS-CoV-2 and a wide spectrum of pathogens and other diseases
39. Performance Evaluation of a Rapid Antigen Test (RAT) during Omicron Pandemic Wave in Greece, Conducted by Different Personnel, and Comparison with Performance in Previous Wave (Alpha Variant) Period
40. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency
41. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases
42. TNFRSF13B/TACI Mutations in Patients with Chronic Rhinosinusitis with Nasal Polyps.
43. Peripheral Inflammatory Markers TNF-α and CCL2 Revisited: Association with Parkinson's Disease Severity.
44. Intensity and Dynamics of Anti-SARS-CoV-2 Immune Responses after BNT162b2 mRNA Vaccination: Implications for Public Health Vaccination Strategies
45. Altered DNA methylation pattern characterizes the peripheral immune cells of patients with autoimmune hepatitis
46. SARS-CoV-2 Sero-Surveillance in Greece: Evolution over Time and Epidemiological Attributes during the Pre-Vaccination Pandemic Era
47. The CD40-1C>T Polymorphism (rs1883832) Affects the Intensity of IgA Antibody Responses After BNT162b2 mRNA COVID-19 Vaccination
48. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature
49. CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding and Signaling Responses
50. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.